Enhancing Week-long Psychological Treatment for PTSD With Ketamine
Status:
Not yet recruiting
Trial end date:
2031-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if the combination of ketamine, vs midazolam, with an
intensive trauma-focused psychotherapy will be more effective in relieving post-traumatic
stress disorder (PTSD). This week-long treatment has the potential to produce a significant
therapeutic effect that otherwise would take months to occur. The study will also focus on
learning about the neurophysiological changes produced by the proposed clinical trial.